The European Union (EU) Joint Programme on Neurodegenerative Disease Research (JPND) initiative has announced a joint transnational call for multinational research on precision medicine for neurodegenerative diseases.
In partnership with the European Commission, it is inviting multinational research teams in 24 countries to submit proposals for multidisciplinary collaborative research projects "to change the trajectory of neurodegenerative diseases" through the development of precision medicine approaches.
“During the last ten years, researchers have progressively uncovered the high complexity and wide diversity of neurodegenerative diseases. We need now to complete and use this massive amount of knowledge to develop targeted approaches to more efficiently fight the dramatic progression of these diseases,” said Professor Philippe Amouyel, University of Lille (France) and Chair of the JPND Management Board.
Proposals submitted should be “novel” and have “ambitious aims” and should relate to one or more of the following diseases: Alzheimer’s disease and other dementias, Parkinson’s disease (PD) and PD-related disorders, prion diseases, motor neuron diseases, Huntington’s disease, spinocerebellar ataxia and spinal muscular atrophy.
Pre-proposals should be submitted before 12 March 2019, while full proposals should be submitted before 25 June 2019.